Posts Tagged ‘innovation’

Year
Month
Category
Clear Filters
Oui by Yoplait

Forget Greek Yogurt, French-Style Yogurt Is Here

June 29, 2017

Health & Obesity

Yogurt fashion is shifting again. Several years ago, people got the hint that all that low-fat yogurt was loaded with sugar. Greek yogurt became a thing. Chobani was hot. Yoplait started tanking. Now low-fat Greek yogurt seems stale. Too tart. Yoplait is seizing the opportunity by going back to its roots in France and launching […]

Read More

What Is Driving Us Ever More Gluten-Free?

June 26, 2017

Health & Obesity, Scientific Meetings & Publications

If you thought that gluten-free everything would be a fast fading memory, think again. Ever more gluten-free products are screaming for your attention. Looking for lipstick without gluten? You got it. Or better yet, you can join the Arbonne multi-level marketing network and help to fill the world with it. Gluten-free marketing is going strong. Setting […]

Read More
Blue Apron Meal Kit

Poised for an IPO, How Far Can Blue Apron Fly?

June 5, 2017

Health & Obesity

Many meal and food delivery services are going belly up. But Blue Apron is ready to take its meal kit business through a public offering to raise a hundred million dollars or more.  After only five years, sales have grown explosively, reaching $795 million in 2016. Losses – $44 million in 2016 – are growing, too. And […]

Read More
Bullet Train

Is Obesity Treatment Innovation Gaining Momentum?

May 5, 2017

Health & Obesity, Scientific Meetings & Publications

We confess. Good news about obesity treatment innovation brings a smile here. The options right now are OK, but limited. So new options are especially welcome. This week brought news of progress on two fronts. DNA-PK: A New Drug Target for Mid-Life Obesity NIH researchers this week published their discovery of a critical role for the […]

Read More
Organic Architecture

A Stent for Obesity Progressing into Larger Trials

May 1, 2017

Health & Obesity, Scientific Meetings & Publications

Making progress with medical devices to treat obesity is a tedious business. And it comes with many ups and downs. But with a more reasonable pathway for FDA approvals these days, more entrepreneurs are trying to advance their ideas. In the latests news, the folks developing a hunger-curbing stent for obesity have raised $2.1 million […]

Read More
Climbing the Dunes

A Steady Climb in Obesity or a Blockbuster Breakthrough?

April 29, 2017

Health & Obesity

Making progress in obesity care continues to be a slow and steady business. Nearly 100 million Americans have this complex chronic disease. But it’s so stigmatized that most people don’t really want to think about it – let alone seek care. But progress continues, with a steady climb on all fronts. News from Novo Nordisk – now […]

Read More
Magic!

Magic Technology Cures for Diabetes and Obesity

April 18, 2017

Health & Obesity, Health Policy, Scientific Meetings & Publications

When people are desperate, magical thinking abounds. Even at the New York Times. Right now, you can read about how Silicon Valley technology is going to “tackle weight loss and diabetes with video chats.” With the help of mock apple cobbler and veggie omelets, an accountant and her husband have lost 120 pounds and avoided taking insulin. […]

Read More
Portrait Of Juliette Courbet As A Sleeping Child,

Is Sleep Becoming Fashionable?

April 17, 2017

Health & Obesity, Health Policy

Now that physical activity has become a fashion statement, will sleep be next? Dubious claims about powerful achievers who can thrive without sleeping much are giving way to sleep as a status symbol. And of course, that opens the door to commerce. A $400 Billion Economic Burden – And an Opportunity The RAND Corporation estimates […]

Read More
Combination

Cana/Phen: Unlocking a Potential New Drug Combination

March 30, 2017

Health & Obesity, Scientific Meetings & Publications

A new study in Diabetes Care provides tantalizing new data on a potential new combination drug for obesity: cana/phen. The study compared a combination of 300 mg of canagliflozin and 15 mg phentermine to each drug alone and to placebo. It was a randomized, controlled study that lasted 26 weeks. The combination was more effective than […]

Read More
For Our Next Generation

Progress on the Next Generation of Obesity Treatment

March 21, 2017

Health & Obesity, Scientific Meetings & Publications

Gratefully, we can report progress on the next generation of obesity treatment. For starters, John Blundell and colleagues have just published a controlled clinical trial of semaglutide in obesity. The study is a tightly controlled experiment to explain how the drug works. And beyond semaglutide, more options for treating obesity are moving into development. The […]

Read More

©2009-2026 ConscienHealth. All rights reserved. | Website Design by Mariela Antunes | Hosting by DTS